Hidradenitis Suppurativa Research Study (64 Weeks)

Adults aged 18+ years old having a diagnosis of hidradenitis suppurativa (HS) for at least one year, may qualify to participate. Individuals must have moderate to severe disease, with a total of at least 5 inflammatory lesions affecting at least 2 different areas of the body. Participants must agree to use topical antiseptics daily, while on study treatment.

Participants will receive investigational medication (active study drug or placebo) via injection. At Week 16 and thereafter, participants who previously received placebo will then receive active study drug. Study medication and study-related care will be provided. Reimbursement for study-related expenses may also be provided.

Study participation will last up to 64 weeks and involve about 23 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Hidradenitis Suppurativa
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more